Cord Blood Registry
 | |
| Subsidiary of AMAG Pharmaceuticals | |
| Founded | 1992 |
| Founder | Tom Moore and Wendy Grant |
| Headquarters | San Bruno, California 94066, United States |
Key people | Geoff Crouse, President & CEO |
| Services | Cord blood stem cells preservation and research |
| Parent | AMAG Pharmaceuticals (2015–present) |
| Website | www.cordblood.com |
Cord Blood Registry is a biotechnology company headquartered in San Bruno, California, founded in 1992 by father and daughter Tom Moore and Wendy Grant.[1]
CBR offers the collection, processing, and long-term cryopreservation of stem cells contained in the umbilical cord blood of newborns, as well as storage of a section of the umbilical cord.[2]
Moore and Grant established the CBR laboratory with David T. Harris, professor of microbiology and immunology. The project began as a pilot partially sponsored by the American Cancer Society at the University of Arizona.[3]
Cord blood is a rich source of stem cells, which have been used in the treatment of over 80 diseases, including leukemia, lymphoma and anemia.[4] CBR processed cord blood has been used in clinical trials investigating conditions including: autism, cerebral palsy, hearing loss, pediatric stroke, and traumatic brain injury.[5]
References
- ↑ "Smart Science. Healthy Families.". cordblood.com. Cord Blood Registry. Retrieved 24 June 2013.
- ↑ "Cord Blood Registry". cordblood.com. Cord Blood Registry. Retrieved 9 Feb 2014.
- ↑ Pangburn, Joe. "Cord Blood Registry: storing the gift of second life". www.insidetucsonbusiness.com. Inside Tucson Business. Retrieved 24 June 2013.
- ↑ "Cord Blood QA". nationalcordbloodprogram.org. New York Blood Center's National Cord Blood Program (NCBP). Retrieved 24 June 2013.
- ↑ "CBR Clinical Trials and Stem Cell Research". cordblood.com. CBR Systems, Inc. Retrieved 21 January 2014.